Market Closed -
Nyse
04:00:02 2024-03-27 pm EDT
5-day change
1st Jan Change
144.7
USD
+1.02%
+3.35%
+17.02%
Presentation Operator MessageOperator (Operator)Ladies and gentlemen, thank you for standing b...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Aptargroup Insider Sold Shares Worth $284,906, According to a Recent SEC Filing
Mar. 12
MT
Aptargroup Insider Sold Shares Worth $499,932, According to a Recent SEC Filing
Mar. 12
MT
Wells Fargo Adjusts AptarGroup's Price Target to $160 From $157, Maintains Overweight Rating
Mar. 07
MT
Aptargroup Insider Sold Shares Worth $4,533,394, According to a Recent SEC Filing
Mar. 05
MT
Tanda, CEO of Aptar: Inflation less of a concern in the pharmaceutical sector
Feb. 12
MT
AptarGroup's Digital Health Business, Biogen to Develop Products for Neurological, Rare Diseases
Feb. 09
MT
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Feb. 09
MT
Transcript : AptarGroup, Inc., Q4 2023 Earnings Call, Feb 09, 2024
Feb. 09
AptarGroup Q4 Adjusted Earnings, Sales Rise; Sets Q1 Outlook
Feb. 08
MT
Earnings Flash (ATR) APTARGROUP Posts Q4 Revenue $838.5M, vs. Street Est of $842.5M
Feb. 08
MT
Earnings Flash (ATR) APTARGROUP Posts Q4 EPS $1.21, vs. Street Est of $1.12
Feb. 08
MT
Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on April 18, 2019.
Feb. 08
CI
AptarGroup, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Feb. 08
CI
AptarGroup Maintains Quarterly Dividend at $0.41 per Share, Payable Feb. 22 to Stockholders of Record Feb. 1
Jan. 18
MT
AptarGroup, Inc. Declares Quarterly Cash Dividend, Payable on February 22, 2024
Jan. 18
CI
Transcript : AptarGroup, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 10:30 AM
Jan. 11
North American Morning Briefing : S&P 500 Futures -2-
Jan. 04
DJ
Baird Upgrades AptarGroup to Outperform From Neutral, Raises Price Target to $150 From $125
Jan. 03
MT
AptarGroup, Inc. Wins US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers
Dec. 04
CI
Aptargroup Insider Sold Shares Worth $306,447, According to a Recent SEC Filing
Nov. 27
MT
AptarGroup, Inc. Seeks M&A
23-10-26
CI
Transcript : AptarGroup, Inc., Q3 2023 Earnings Call, Oct 26, 2023
23-10-26
AptarGroup Posts Higher Q3 Adjusted Earnings, Sales; Issues Q4 EPS Outlook
23-10-25
MT
AptarGroup, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023
23-10-25
CI
Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on April 18, 2019.
23-10-25
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and consumer product dispensing, sealing and active packaging solutions and services. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma includes operations that sells dispensing systems and sealing solutions and also manufactures and sells elastomeric primary packaging components. The Company's products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The Aptar Beauty segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health care, injectables, and active material science solutions markets. The Aptar Closures business serves multiple markets, including food, beverage, personal care, home care, beauty and healthcare. This segment offers food protection business and elastomeric flow-control technology business.
More about the company
Last Close Price
144.7
USD
Average target price
147.7
USD
Spread / Average Target
+2.08%
Consensus
1st Jan change
Capi.
+17.02% 9.55B -10.25% 7.01B -7.69% 1.49B +17.60% 1.32B +8.40% 1.35B -17.11% 1.1B +6.60% 1.05B +18.77% 856M +17.37% 830M -0.31% 701M
Plastic Containers & Packaging
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1